tusso rhinathiol 10 mg zuigtabl.
opella healthcare belgium sa-nv - dextromethorfanhydrobromide 10 mg - zuigtablet - 10 mg - dextromethorfanhydrobromide 10 mg - dextromethorphan
bisolvon droge hoest 2 mg/ml siroop
opella healthcare belgium sa-nv - dextromethorfanhydrobromide 0,2 g/100 ml - siroop - 2 mg/ml - dextromethorfanhydrobromide 2 mg/ml - dextromethorphan
vicks droge hoest 7.33 mg zuigtabl.
p&g health belgium s.p.r.l.-b.v.b.a. - dextromethorfan 7,33 mg - zuigtablet - 7,33 mg - dextromethorfan 7.33 mg - dextromethorphan
zirorphan 1,5 mg/ml siroop
i.d. phar s.p.r.l.-b.v.b.a. - dextromethorfanhydrobromide 1,5 mg/ml - siroop - 1,5 mg/ml - dextromethorfanhydrobromide 1.5 mg/ml - dextromethorphan
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - multiple myeloma - antineoplastische middelen - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
ambrisentan aop 10 mg filmomhulde tabletten
aop orphan pharmaceuticals ag wilhelminenstrasse 91/ii f 1160 vienna (oostenrijk) - ambrisentan 10 mg/stuk - filmomhulde tablet - allurarood ac aluminium lak (e 129) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; lactose 1-water ; lecithine, soya (e 322) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; polyvinylalcohol (e 1203) ; talk (e 553 b) ; titaandioxide (e 171), allurarood ac aluminium lak (e 129) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; lactose 1-water ; lecithine, soya (e 322) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; polyvinylalcohol (e1203) ; talk (e 553 b) ; titaandioxide (e 171)
ambrisentan aop 5 mg filmomhulde tabletten
aop orphan pharmaceuticals ag wilhelminenstrasse 91/ii f 1160 vienna (oostenrijk) - ambrisentan 5 mg/stuk - filmomhulde tablet - allurarood ac aluminium lak (e 129) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; lactose 1-water ; lecithine, soya (e 322) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; polyvinylalcohol (e 1203) ; talk (e 553 b) ; titaandioxide (e 171), allurarood ac aluminium lak (e 129) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; lactose 1-water ; lecithine, soya (e 322) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; polyvinylalcohol (e1203) ; talk (e 553 b) ; titaandioxide (e 171)
abibam 250 mg, tabletten
abirateronacetaat - tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551)
abibam 500 mg, filmomhulde tabletten
abirateronacetaat - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; polyethyleenglycol (e 1521) ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)
abirateron 1a pharma 1000 mg, filmomhulde tabletten
abirateronacetaat 1000 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat ; polyvinylalcohol (e 1203) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; polyvinylalcohol (e1203) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)